US patent reforms could re-establish gene patent eligibility, industry experts warn

06-06-2019

US patent reforms could re-establish gene patent eligibility, industry experts warn

Olivier Le Moal / Shutterstock.com

A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.


US Patent Act, patent eligibility, gene patenting, Senate Judiciary Subcommittee on Intellectual Property, Chris Coons, Thom Tillis

LSIPR